INHIBITION OF THE CD95 LIGANDO / RECEIVER SYSTEM FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND INJURIES.

摘要

Use of a CD95 ligand inhibitor selected from (a) an anti-CD95 ligand inhibitor antibody or an antigen binding fragment thereof, (b) a soluble CD95 receptor molecule or a CD95 ligand binding portion thereof, for the manufacture of a medicament for the treatment of brain or spinal cord injuries, wherein said medicament does not comprise a TNF ligand / receptor inhibitor.